1. Market Research
  2. > Pharmaceutical

Pharmaceutical Industry: Comprehensive Market Analysis

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
99 votes

Global Pharmaceutical Industry Overview

The pharmaceutical industry consists of companies involved in the research, development and marketing of drugs and biologics.

The pharmaceutical market was valued at $1 trillion in 2013, according to IMS. The market grew at a 4% compound annual growth rate (CAGR) from 2009 to 2013. It grew well in 2010 and 2011 before a decline in growth in 2012 and 2013.

Pharmaceutical Market Value in USD from 2009 to 2013

The pharmaceutical market was driven by a rise in healthcare spending and high growth in both emerging markets and the biologics segment. In 2013, cancer was the largest segment, accounting for 7% ($67 billion) of the global industry. This was closely followed by the pain and diabetes segments with shares of 6% and 5% respectively, according to IMS.

Key International Markets

  • North America was the largest market in 2013, with revenues exceeding $340 billion.
  • This was followed by Europe with revenues of $224 billion according to IMS.
  • Emerging countries in Asia and Latin America are forecast to grow rapidly. Increase in spending in these countries will be driven by rising incidence of disease, favorable government policies and improving healthcare infrastructure (and the multiplication of drug stores and pharmacies in large cities.

 Top Pharmaceutical Regional Markets' Growth in 2013

Pharmaceutical Key Players

Novartis was the pharmaceutical market leader in 2013 (thanks to a state-of-the-art drug discovery and development department) with revenues of $51 billion and a market share of 5%. Primary contributors to its sales were the drugs Gilenya and Affinitor. In 2014 Novartis is expected to file 10 new drugs with the U.S.’s Federal Drugs Administration (FDA). Pfizer was close behind Novartis with a 4% shareof the global market according to IMS. Pfizer too is expected to file six new drugs with the FDA in 2014.

The top ten players are forecast to collectively lose share from 35% in 2013 to 30% in 2017, according to IMS. Patent expiries over the next few years will eat into the revenues of most companies during this period.

Sanofi potential loss due to patent expiries is estimated to reach up to $8.1 billion. The company is then followed by Novartis, Roche, Astra-Zeneca and Eli Lilly with respectively potential losses of 7.7, 7.2, 6.7 and 6 billion dollars.  

Pharmaceutical Sales Forecast 

Pharmaceutical industry trends show that the global market is set to show steady growth in the next five years at a CAGR of 4-5%. Innovative on-prescritpion drugs and over-the-counter drugs entering the market and biologics such as targeted therapies for cancer will be key in driving growth.

Read more »

Share
24/7 Customer Support

Talk to Sam

+44 20 8816 8032

1-10 of about 32 000 reports

Global Pharmaceutical Industry

  • May 2016
    9 pages
  • Pharmaceutical  

    Pharmaceutical  

  • World  

View report >

Pharmaceutical Industry in the US

  • March 2016
    43 pages
  • Pharmaceutical  

    Organic Compoun  

  • United States  

View report >

Pharmaceutical Industry in Europe

  • May 2016
    8 pages
  • Pharmaceutical  

  • Europe  

    China  

View report >

Pharmaceutical Markets in Singapore and Asia

  • February 2014
    11 pages
  • Singapore  

    Asia  

    World  

View report >

Pharmaceutical Forecast Statistics in Japan

  • February 2016
    6 pages
  • Pharmaceutical  

    Healthcare  

  • Japan  

    Asia  

    World  

View report >

Pharmaceutical Industry in France

  • May 2016
    61 pages
  • France  

    United States  

View report >

Pharmaceutical Industry in Germany

  • March 2016
    11 pages
  • Germany  

    China  

    Europe  

View report >

Pharmaceutical Industry in Italy

  • July 2015
    49 pages
  • Pharmaceutical  

  • Italy  

    Europe  

    World  

View report >

Pharmaceutical Industry in the UK

  • February 2016
    12 pages
  • Pharmaceutical  

    Pharmaceutical  

  • United Kingdom  

View report >

Pharmaceutical Markets in Canada

  • March 2016
    53 pages
  • Prescription Dr  

  • Canada  

    North America  

View report >


About 22 000 reports

Purchase Reports From Reputable Market Research Publishers
(From € 60 - € 18 800)

Immunodiagnostics 2016-2020: Clinical Chemistry, Drugs of Abuse, Endocrine Function, Immunoproteins, Special Chemistry, Therapeutic Drug Monitoring (TDM), Tumor Markers--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts f

Immunodiagnostics 2016-2020: Clinical Chemistry, Drugs of Abuse, Endocrine Function, Immunoproteins, Special Chemistry, Therapeutic Drug Monitoring (TDM), Tumor Markers--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts f

  • € 18 800
  • Industry report
  • May 2016
  • by Venture Planning Group

Complete report PDF $37,500, DataPack (500 tables) $23,500. The report is available by geographic region, country, section, market segment, test category, and individual assay. VPGMarketResearch.com new ...

2016-2020 Global Clinical Chemistry And Immunodiagnosti ...

March 2016 € 18 800

2016-2020 Future Horizons And Growth Strategies In The ...

March 2016 € 18 800

2016-2020 New Frontiers In The Global Clinical Chemist ...

March 2016 € 18 800

2016-2020 World Clinical Chemistry And Immunodiagnostic ...

March 2016 € 18 800

2016-2020 Global Immunodiagnostic Markets: Clinical Che ...

March 2016 € 18 800

2016-2020 Poc/decentralized Diagnostic Testing Market: ...

May 2016 € 13 280

2016-2020 Poc/point-of-care Diagnostic Testing Market: ...

March 2016 € 13 280

2016-2020 New Frontiers In The Point-of-care/poc Diagn ...

March 2016 € 13 280

2016-2020 Clinical Chemistry And Immunodiagnostics: A M ...

March 2016 € 12 720

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.